LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 15

Search options

  1. Article: Immunogenic cell stress and injury versus immunogenic cell death: implications for improving cancer treatment with immune checkpoint blockade.

    Sriram, Ganapathy / Emmons, Tiffany R / Milling, Lauren E / Irvine, Darrell J / Yaffe, Michael B

    Molecular & cellular oncology

    2022  Volume 9, Issue 1, Page(s) 2039038

    Abstract: Inducing immunogenic tumor cell death to stimulate the response to immune checkpoint blockade has not yet been effectively translated into clinical practice. We recently discovered that stressed/injured but still viable tumor cells are critical for T- ... ...

    Abstract Inducing immunogenic tumor cell death to stimulate the response to immune checkpoint blockade has not yet been effectively translated into clinical practice. We recently discovered that stressed/injured but still viable tumor cells are critical for T-cell priming and substantially improve responses to systemic anti-PD1/CTLA4. Therapeutic tumor cell injury, rather than complete killing, in the tumor microenvironment may enhance efficacy of immunotherapy in various cancers.
    Language English
    Publishing date 2022-04-03
    Publishing country United States
    Document type Journal Article
    ISSN 2372-3556
    ISSN 2372-3556
    DOI 10.1080/23723556.2022.2039038
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Framework for in vivo T cell screens.

    Milling, Lauren E / Markson, Samuel C / Tjokrosurjo, Qin / Derosia, Nicole M / Streeter, Ivy S L / Hickok, Grant H / Lemmen, Ashlyn M / Nguyen, Thao H / Prathima, Priyamvada / Fithian, William / Schwartz, Marc A / Hacohen, Nir / Doench, John G / LaFleur, Martin W / Sharpe, Arlene H

    The Journal of experimental medicine

    2024  Volume 221, Issue 4

    Abstract: In vivo T cell screens are a powerful tool for elucidating complex mechanisms of immunity, yet there is a lack of consensus on the screen design parameters required for robust in vivo screens: gene library size, cell transfer quantity, and number of mice. ...

    Abstract In vivo T cell screens are a powerful tool for elucidating complex mechanisms of immunity, yet there is a lack of consensus on the screen design parameters required for robust in vivo screens: gene library size, cell transfer quantity, and number of mice. Here, we describe the Framework for In vivo T cell Screens (FITS) to provide experimental and analytical guidelines to determine optimal parameters for diverse in vivo contexts. As a proof-of-concept, we used FITS to optimize the parameters for a CD8+ T cell screen in the B16-OVA tumor model. We also included unique molecular identifiers (UMIs) in our screens to (1) improve statistical power and (2) track T cell clonal dynamics for distinct gene knockouts (KOs) across multiple tissues. These findings provide an experimental and analytical framework for performing in vivo screens in immune cells and illustrate a case study for in vivo T cell screens with UMIs.
    MeSH term(s) Animals ; Mice ; CD8-Positive T-Lymphocytes ; Gene Knockout Techniques
    Language English
    Publishing date 2024-02-27
    Publishing country United States
    Document type Journal Article
    ZDB-ID 218343-2
    ISSN 1540-9538 ; 0022-1007
    ISSN (online) 1540-9538
    ISSN 0022-1007
    DOI 10.1084/jem.20230699
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: THE EFFICACY OF HYPNOSIS AS A TREATMENT FOR ANXIETY:

    Valentine, Keara E / Milling, Leonard S / Clark, Lauren J / Moriarty, Caitlin L

    The International journal of clinical and experimental hypnosis

    2019  Volume 67, Issue 3, Page(s) 336–363

    Abstract: This meta-analysis quantifies the effectiveness of hypnosis in treating anxiety. Included studies were required to utilize a between-subjects or mixed-model design in which a hypnosis intervention was compared with a control condition in alleviating the ... ...

    Abstract This meta-analysis quantifies the effectiveness of hypnosis in treating anxiety. Included studies were required to utilize a between-subjects or mixed-model design in which a hypnosis intervention was compared with a control condition in alleviating the symptoms of anxiety. Of 399 records screened, 15 studies incorporating 17 trials of hypnosis met the inclusion criteria. At the end of active treatment, 17 trials produced a mean weighted effect size of 0.79 (
    MeSH term(s) Anxiety/therapy ; Humans ; Hypnosis/methods ; Treatment Outcome
    Language English
    Publishing date 2019-06-27
    Publishing country England
    Document type Journal Article ; Meta-Analysis
    ZDB-ID 218267-1
    ISSN 1744-5183 ; 0020-7144
    ISSN (online) 1744-5183
    ISSN 0020-7144
    DOI 10.1080/00207144.2019.1613863
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Delivering safer immunotherapies for cancer.

    Milling, Lauren / Zhang, Yuan / Irvine, Darrell J

    Advanced drug delivery reviews

    2017  Volume 114, Page(s) 79–101

    Abstract: Cancer immunotherapy is now a powerful clinical reality, with a steady progression of new drug approvals and a massive pipeline of additional treatments in clinical and preclinical development. However, modulation of the immune system can be a double- ... ...

    Abstract Cancer immunotherapy is now a powerful clinical reality, with a steady progression of new drug approvals and a massive pipeline of additional treatments in clinical and preclinical development. However, modulation of the immune system can be a double-edged sword: Drugs that activate immune effectors are prone to serious non-specific systemic inflammation and autoimmune side effects. Drug delivery technologies have an important role to play in harnessing the power of immune therapeutics while avoiding on-target/off-tumor toxicities. Here we review mechanisms of toxicity for clinically-relevant immunotherapeutics, and discuss approaches based in drug delivery technology to enhance the safety and potency of these treatments. These include strategies to merge drug delivery with adoptive cellular therapies, targeting immunotherapies to tumors or select immune cells, and localizing therapeutics intratumorally. Rational design employing lessons learned from the drug delivery and nanomedicine fields has the potential to facilitate immunotherapy reaching its full potential.
    MeSH term(s) Adoptive Transfer ; Animals ; Drug Delivery Systems ; Humans ; Immune System/drug effects ; Immune System/immunology ; Immunotherapy/adverse effects ; Immunotherapy/methods ; Immunotherapy/trends ; Nanomedicine ; Neoplasms/immunology ; Neoplasms/pathology ; Neoplasms/therapy
    Language English
    Publishing date 2017-05-22
    Publishing country Netherlands
    Document type Journal Article ; Review ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 639113-8
    ISSN 1872-8294 ; 0169-409X
    ISSN (online) 1872-8294
    ISSN 0169-409X
    DOI 10.1016/j.addr.2017.05.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Engineering kinetics of TLR7/8 agonist release from bottlebrush prodrugs enables tumor-focused immune stimulation.

    Bhagchandani, Sachin H / Vohidov, Farrukh / Milling, Lauren E / Tong, Evelyn Yuzhou / Brown, Christopher M / Ramseier, Michelle L / Liu, Bin / Fessenden, Timothy B / Nguyen, Hung V-T / Kiel, Gavin R / Won, Lori / Langer, Robert S / Spranger, Stefani / Shalek, Alex K / Irvine, Darrell J / Johnson, Jeremiah A

    Science advances

    2023  Volume 9, Issue 16, Page(s) eadg2239

    Abstract: Imidazoquinolines (IMDs), such as resiquimod (R848), are of great interest as potential cancer immunotherapies because of their ability to activate Toll-like receptor 7 (TLR7) and/or TLR8 on innate immune cells. Nevertheless, intravenous administration ... ...

    Abstract Imidazoquinolines (IMDs), such as resiquimod (R848), are of great interest as potential cancer immunotherapies because of their ability to activate Toll-like receptor 7 (TLR7) and/or TLR8 on innate immune cells. Nevertheless, intravenous administration of IMDs causes severe immune-related toxicities, and attempts to improve their tissue-selective exposure while minimizing acute systemic inflammation have proven difficult. Here, using a library of R848 "bottlebrush prodrugs" (BPDs) that differ only by their R848 release kinetics, we explore how the timing of R848 exposure affects immune stimulation in vitro and in vivo. These studies led to the discovery of R848-BPDs that exhibit optimal activation kinetics to achieve potent stimulation of myeloid cells in tumors and substantial reductions in tumor growth following systemic administration in mouse syngeneic tumor models without any observable systemic toxicity. These results suggest that release kinetics can be tuned at the molecular level to provide safe yet effective systemically administered immunostimulant prodrugs for next-generation cancer immunotherapies.
    MeSH term(s) Mice ; Animals ; Prodrugs/pharmacology ; Toll-Like Receptor 7/agonists ; Kinetics ; Adjuvants, Immunologic/pharmacology ; Neoplasms/drug therapy
    Chemical Substances Prodrugs ; Toll-Like Receptor 7 ; Adjuvants, Immunologic
    Language English
    Publishing date 2023-04-19
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2810933-8
    ISSN 2375-2548 ; 2375-2548
    ISSN (online) 2375-2548
    ISSN 2375-2548
    DOI 10.1126/sciadv.adg2239
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: X-CHIME enables combinatorial, inducible, lineage-specific and sequential knockout of genes in the immune system.

    LaFleur, Martin W / Lemmen, Ashlyn M / Streeter, Ivy S L / Nguyen, Thao H / Milling, Lauren E / Derosia, Nicole M / Hoffman, Zachary M / Gillis, Jacob E / Tjokrosurjo, Qin / Markson, Samuel C / Huang, Amy Y / Anekal, Praju V / Montero Llopis, Paula / Haining, W Nicholas / Doench, John G / Sharpe, Arlene H

    Nature immunology

    2023  Volume 25, Issue 1, Page(s) 178–188

    Abstract: Annotation of immunologic gene function in vivo typically requires the generation of knockout mice, which is time consuming and low throughput. We previously developed CHimeric IMmune Editing (CHIME), a CRISPR-Cas9 bone marrow delivery system for ... ...

    Abstract Annotation of immunologic gene function in vivo typically requires the generation of knockout mice, which is time consuming and low throughput. We previously developed CHimeric IMmune Editing (CHIME), a CRISPR-Cas9 bone marrow delivery system for constitutive, ubiquitous deletion of single genes. Here we describe X-CHIME, four new CHIME-based systems for modular and rapid interrogation of gene function combinatorially (C-CHIME), inducibly (I-CHIME), lineage-specifically (L-CHIME) or sequentially (S-CHIME). We use C-CHIME and S-CHIME to assess the consequences of combined deletion of Ptpn1 and Ptpn2, an embryonic lethal gene pair, in adult mice. We find that constitutive deletion of both PTPN1 and PTPN2 leads to bone marrow hypoplasia and lethality, while inducible deletion after immune development leads to enteritis and lethality. These findings demonstrate that X-CHIME can be used for rapid mechanistic evaluation of genes in distinct in vivo contexts and that PTPN1 and PTPN2 have some functional redundancy important for viability in adult mice.
    MeSH term(s) Mice ; Animals ; CRISPR-Cas Systems/genetics ; Protein Tyrosine Phosphatase, Non-Receptor Type 2/genetics ; Mice, Knockout ; Immune System ; Gene Editing
    Chemical Substances Protein Tyrosine Phosphatase, Non-Receptor Type 2 (EC 3.1.3.48) ; Ptpn2 protein, mouse (EC 3.1.3.48)
    Language English
    Publishing date 2023-11-27
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2016987-5
    ISSN 1529-2916 ; 1529-2908
    ISSN (online) 1529-2916
    ISSN 1529-2908
    DOI 10.1038/s41590-023-01689-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: ABC triblock bottlebrush copolymer-based injectable hydrogels: design, synthesis, and application to expanding the therapeutic index of cancer immunochemotherapy.

    Vohidov, Farrukh / Milling, Lauren E / Chen, Qixian / Zhang, Wenxu / Bhagchandani, Sachin / Nguyen, Hung V-T / Irvine, Darrell J / Johnson, Jeremiah A

    Chemical science

    2020  Volume 11, Issue 23, Page(s) 5974–5986

    Abstract: Bottlebrush copolymers are a versatile class of macromolecular architectures with broad applications in the fields of drug delivery, self-assembly, and polymer networks. Here, the modular nature of graft-through ring-opening metathesis polymerization ( ... ...

    Abstract Bottlebrush copolymers are a versatile class of macromolecular architectures with broad applications in the fields of drug delivery, self-assembly, and polymer networks. Here, the modular nature of graft-through ring-opening metathesis polymerization (ROMP) is exploited to synthesize "ABC" triblock bottlebrush copolymers (TBCs) from polylactic acid (PLA), polyethylene glycol (PEG), and poly(
    Language English
    Publishing date 2020-06-01
    Publishing country England
    Document type Journal Article
    ZDB-ID 2559110-1
    ISSN 2041-6539 ; 2041-6520
    ISSN (online) 2041-6539
    ISSN 2041-6520
    DOI 10.1039/d0sc02611e
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The injury response to DNA damage in live tumor cells promotes antitumor immunity.

    Sriram, Ganapathy / Milling, Lauren E / Chen, Jung-Kuei / Kong, Yi Wen / Joughin, Brian A / Abraham, Wuhbet / Swartwout, Susanne / Handly, Erika D / Irvine, Darrell J / Yaffe, Michael B

    Science signaling

    2021  Volume 14, Issue 705, Page(s) eabc4764

    Abstract: Although immune checkpoint blockade (ICB) has strong clinical benefit for treating some tumor types, it fails in others, indicating a need for additional modalities to enhance the ICB effect. Here, we identified one such modality by using DNA damage to ... ...

    Abstract Although immune checkpoint blockade (ICB) has strong clinical benefit for treating some tumor types, it fails in others, indicating a need for additional modalities to enhance the ICB effect. Here, we identified one such modality by using DNA damage to create a live, injured tumor cell adjuvant. Using an optimized ex vivo coculture system, we found that treating tumor cells with specific concentrations of etoposide, mitoxantrone, or doxorubicin markedly enhanced dendritic cell–mediated T cell activation. These immune-enhancing effects of DNA damage did not correlate with immunogenic cell death markers or with the extent of apoptosis or necroptosis; instead, these effects were mediated by live injured cells with activation of the DNA-PK, ATR, NF-κB, p38 MAPK, and RIPK1 signaling pathways. In mice, intratumoral injection of ex vivo etoposide–treated tumor cells in combination with systemic ICB (by anti-PD-1 and anti-CTLA4 antibodies) increased the number of intratumoral CD103
    MeSH term(s) DNA Damage
    Language English
    Publishing date 2021-10-19
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2417226-1
    ISSN 1937-9145 ; 1945-0877
    ISSN (online) 1937-9145
    ISSN 1945-0877
    DOI 10.1126/scisignal.abc4764
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity.

    Agarwal, Yash / Milling, Lauren E / Chang, Jason Y H / Santollani, Luciano / Sheen, Allison / Lutz, Emi A / Tabet, Anthony / Stinson, Jordan / Ni, Kaiyuan / Rodrigues, Kristen A / Moyer, Tyson J / Melo, Mariane B / Irvine, Darrell J / Wittrup, K Dane

    Nature biomedical engineering

    2022  Volume 6, Issue 2, Page(s) 129–143

    Abstract: Anti-tumour inflammatory cytokines are highly toxic when administered systemically. Here, in multiple syngeneic mouse models, we show that the intratumoural injection of recombinantly expressed cytokines bound tightly to the common vaccine adjuvant ... ...

    Abstract Anti-tumour inflammatory cytokines are highly toxic when administered systemically. Here, in multiple syngeneic mouse models, we show that the intratumoural injection of recombinantly expressed cytokines bound tightly to the common vaccine adjuvant aluminium hydroxide (alum) (via ligand exchange between hydroxyls on the surface of alum and phosphoserine residues tagged to the cytokine by an alum-binding peptide) leads to weeks-long retention of the cytokines in the tumours, with minimal side effects. Specifically, a single dose of alum-tethered interleukin-12 induced substantial interferon-γ-mediated T-cell and natural-killer-cell activities in murine melanoma tumours, increased tumour antigen accumulation in draining lymph nodes and elicited robust tumour-specific T-cell priming. Moreover, intratumoural injection of alum-anchored cytokines enhanced responses to checkpoint blockade, promoting cures in distinct poorly immunogenic syngeneic tumour models and eliciting control over metastases and distant untreated lesions. Intratumoural treatment with alum-anchored cytokines represents a safer and tumour-agnostic strategy to improving local and systemic anticancer immunity.
    MeSH term(s) Alum Compounds/pharmacology ; Animals ; Cytokines ; Immunotherapy ; Interleukin-12 ; Mice
    Chemical Substances Alum Compounds ; Cytokines ; Interleukin-12 (187348-17-0) ; aluminum sulfate (34S289N54E)
    Language English
    Publishing date 2022-01-10
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ISSN 2157-846X
    ISSN (online) 2157-846X
    DOI 10.1038/s41551-021-00831-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity.

    Dane, Eric L / Belessiotis-Richards, Alexis / Backlund, Coralie / Wang, Jianing / Hidaka, Kousuke / Milling, Lauren E / Bhagchandani, Sachin / Melo, Mariane B / Wu, Shengwei / Li, Na / Donahue, Nathan / Ni, Kaiyuan / Ma, Leyuan / Okaniwa, Masanori / Stevens, Molly M / Alexander-Katz, Alfredo / Irvine, Darrell J

    Nature materials

    2022  Volume 21, Issue 6, Page(s) 710–720

    Abstract: Activation of the innate immune STimulator of INterferon Genes (STING) pathway potentiates antitumour immunity, but systemic delivery of STING agonists to tumours is challenging. We conjugated STING-activating cyclic dinucleotides (CDNs) to PEGylated ... ...

    Abstract Activation of the innate immune STimulator of INterferon Genes (STING) pathway potentiates antitumour immunity, but systemic delivery of STING agonists to tumours is challenging. We conjugated STING-activating cyclic dinucleotides (CDNs) to PEGylated lipids (CDN-PEG-lipids; PEG, polyethylene glycol) via a cleavable linker and incorporated them into lipid nanodiscs (LNDs), which are discoid nanoparticles formed by self-assembly. Compared to state-of-the-art liposomes, intravenously administered LNDs carrying CDN-PEG-lipid (LND-CDNs) exhibited more efficient penetration of tumours, exposing the majority of tumour cells to STING agonist. A single dose of LND-CDNs induced rejection of established tumours, coincident with immune memory against tumour rechallenge. Although CDNs were not directly tumoricidal, LND-CDN uptake by cancer cells correlated with robust T-cell activation by promoting CDN and tumour antigen co-localization in dendritic cells. LNDs thus appear promising as a vehicle for robust delivery of compounds throughout solid tumours, which can be exploited for enhanced immunotherapy.
    MeSH term(s) Humans ; Immunotherapy ; Lipids ; Membrane Proteins/metabolism ; Membrane Proteins/pharmacology ; Nanoparticles/therapeutic use ; Neoplasms/drug therapy
    Chemical Substances Lipids ; Membrane Proteins
    Language English
    Publishing date 2022-05-23
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2088679-2
    ISSN 1476-4660 ; 1476-1122
    ISSN (online) 1476-4660
    ISSN 1476-1122
    DOI 10.1038/s41563-022-01251-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top